Create
Log in
Enquire now
Axcella
Axcella is a clinical-stage biotechnology company.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
Also Known As
Axcella Health
B2X
B2B
CEO
Bill Hinshaw
CIK Number
1,633,070
0
Legal Name
Axcella Health Inc.
Company Operating Status
Active
Competitors
Aspen Neuroscience
Contact Page URL
axcellatx.com/contact/
Country
United States
0
Crunchbase URL
crunchbase.com/organiz.../axcella
Date Incorporated
2010
Email Address
Axcella@vlpc.com
info@axcellatx.com
0
Fax Number
617-441-6243
0
Founded Date
January 1, 2010
Founder
Noubar Afeyan
David Berry (inventor)
Geoffrey von Maltzahn
Full Address
840 MEMORIAL DR., 3RD FLOOR CAMBRIDGE, 02139 MA USA
0
Industry
Biology
Consumer biotechnology
Healthcare
Life science
Biopharmaceutical
Enzyme kinetics
Pharmacokinetics
Chemistry
Drug metabolism
Technology
•••
Investors
Flagship Pioneering
Enso Ventures
Fidelity Investments
Gurnet Point Capital
Nestlé Health Science
Latest Funding Round Date
November 2018
Latest Funding Round Amount (USD)
59,000,000
Latest Funding Type
Series E
LinkedIn URL
@company/axcella-health
Location
Cambridge, Massachusetts
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
18
Phone Number
+18573202200
0
Pitchbook URL
pitchbook.com/profiles.../58860-46
Place of Incorporation
Delaware
0
Previous Name
Pronutria Biosciences, Inc.
0
SIC Code
2,836
0
Exchange
Nasdaq
0
Stock Symbol
AXLA
0
Ticker Symbol
AXLA
0
Total Funding Amount (USD)
179,599,993
Twitter URL
@axcellahealth
Official Website
axcellahealth.com
Wikidata ID
Q30271862
Find more companies like Axcella
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE